Fuller & Thaler Asset Management Inc. lessened its holdings in shares of Chemours Company (The) (NYSE:CC) by 51.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 150,435 shares of the specialty chemicals company’s stock after selling 161,000 shares during the quarter. Fuller & Thaler Asset Management Inc. owned about 0.08% of Chemours Company (The) worth $7,614,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of CC. Financial Architects Inc raised its stake in Chemours Company (The) by 1,230.3% during the 2nd quarter. Financial Architects Inc now owns 2,940 shares of the specialty chemicals company’s stock valued at $111,000 after purchasing an additional 2,719 shares during the period. Acrospire Investment Management LLC raised its stake in Chemours Company (The) by 3.4% during the 2nd quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock valued at $117,000 after purchasing an additional 100 shares during the period. Benjamin F. Edwards & Company Inc. raised its stake in Chemours Company (The) by 2,138.8% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 3,112 shares of the specialty chemicals company’s stock valued at $118,000 after purchasing an additional 2,973 shares during the period. Smithfield Trust Co. raised its stake in Chemours Company (The) by 521.4% during the 2nd quarter. Smithfield Trust Co. now owns 4,791 shares of the specialty chemicals company’s stock valued at $182,000 after purchasing an additional 4,020 shares during the period. Finally, Alps Advisors Inc. bought a new stake in Chemours Company (The) during the 2nd quarter valued at approximately $202,000. 74.04% of the stock is currently owned by institutional investors.

In other Chemours Company (The) news, SVP David C. Shelton sold 19,000 shares of Chemours Company (The) stock in a transaction on Thursday, October 5th. The stock was sold at an average price of $53.68, for a total transaction of $1,019,920.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP David C. Shelton sold 13,337 shares of Chemours Company (The) stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $48.48, for a total value of $646,577.76. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 76,520 shares of company stock valued at $4,008,293. 1.14% of the stock is currently owned by corporate insiders.

Chemours Company (NYSE:CC) traded down $0.11 during trading hours on Thursday, reaching $52.86. The company’s stock had a trading volume of 1,255,851 shares, compared to its average volume of 2,719,832. The company has a current ratio of 2.19, a quick ratio of 1.63 and a debt-to-equity ratio of 5.07. Chemours Company has a 1-year low of $20.76 and a 1-year high of $58.08. The company has a market cap of $9,808.09, a P/E ratio of 18.78, a price-to-earnings-growth ratio of 0.92 and a beta of 3.59.

Chemours Company (The) (NYSE:CC) last released its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.01 by $0.11. Chemours Company (The) had a return on equity of 116.80% and a net margin of 4.86%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the company posted $0.61 EPS. The company’s revenue was up 13.3% compared to the same quarter last year. equities research analysts expect that Chemours Company will post 3.73 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Monday, November 20th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Friday, November 17th. Chemours Company (The)’s dividend payout ratio (DPR) is presently 8.28%.

ILLEGAL ACTIVITY NOTICE: This piece was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another site, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this piece can be read at https://www.watchlistnews.com/chemours-company-the-cc-position-cut-by-fuller-thaler-asset-management-inc/1721955.html.

Several analysts recently issued reports on CC shares. Zacks Investment Research raised Chemours Company (The) from a “hold” rating to a “buy” rating and set a $57.00 target price on the stock in a research note on Thursday, November 9th. BidaskClub downgraded Chemours Company (The) from a “buy” rating to a “hold” rating in a research note on Friday, August 11th. UBS Group AG lifted their target price on Chemours Company (The) from $50.00 to $59.00 and gave the company a “neutral” rating in a research note on Friday, November 3rd. Barclays PLC lifted their target price on Chemours Company (The) from $55.00 to $58.00 and gave the company an “overweight” rating in a research note on Monday, November 6th. Finally, Citigroup Inc. lifted their price objective on Chemours Company (The) from $45.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 4th. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. Chemours Company (The) currently has an average rating of “Buy” and an average target price of $53.89.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.